A weekly podcast for physicians interested in evidence based medicine and rheumatology. Find the papers at ebrheum.com
…
continue reading
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
Explore rheumatological conditions with the clinical experts. This monthly podcast covers everything from disease presentation to diagnosis, treatment and management. Some months, real cases are used to bring the discussion to life.
…
continue reading
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
…
continue reading
Listen to the latest news and views from the British Society for Rheumatology.
…
continue reading
Covering everything rheumatology from how to get started, the opportunities and benefits, plus inspiring stories and lived experience from the field.
…
continue reading
MedEdTalks Rheumatology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on rheumatology topics, such as GCA, ANCA-Associated Vasculitis, Pemphigus Vulgaris, Lupus, Biosimilars, RA, axSpA, irAEs and PSA and includes interviews with Dr. Leonard Calabrese, Dr. Grace Wright, Dr. Jeff Kaine, Dr. John Tesser, Dr. Adam Brown, Dr. John Stone and Dr. Ronald Harris
…
continue reading
Editors at The Lancet Rheumatology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from disorders of the immune system to sex and gender in research design, the transitional care for adolescent patients with rheumatic diseases to care for undocumented immigrants, and more.
…
continue reading
1
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek
39:27
39:27
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
39:27
At ACR23 I had a twitter-disagreement about steroid tapers from PEXIVAS with Mike Walsh, the lead author on the PEXIVAS trial. He kindly agreed to join me for a moderated discussion. Loved hearing his perspective and have to admit he pulled me closer to his practice... but not all the way there. Longer podcast than usual but I prefer to release aud…
…
continue reading
1
Ep 29. Cancer treatments and rheumatic disease
29:17
29:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
29:17
In this episode, Dr Mariam Malik talks to Prof Andrew Cope about cancer treatments and rheumatic disease, covering immune checkpoint inhibitors, the adverse events and rheumatological conditions they can cause, and how to manage them.Oleh British Society for Rheumatology
…
continue reading
1
AxSpA Podcast: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment
32:38
32:38
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
32:38
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the risk of acute anterior uveitis across different bDMARDs in patients with AS. Our faculty then move on to discuss another publicati…
…
continue reading
1
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
24:19
24:19
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:19
Rheum4Debate is back! In this episode I moderated a debate between two pulmonologists about RA-ILD. As a reminder, Rheum4Debate is an Oxford-style debate show, where two debators disagree over a motion during 3 rounds of discussion. The motion for todays show was: “Asymptomatic patients with rheumatoid arthritis and high risk features for interstit…
…
continue reading
1
E109: Abatacept for Pre-RA - the ARIAA Study
16:22
16:22
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
16:22
Nice study this week on an important topic. Can we prevent the development of rheumatoid arthritis by initiating DMARDs during a preclinical phase? Lots to discuss: what does it mean to be "pre-clinical?" How does this fit with other studies of this nature? Check it out! https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02650-8/ful…
…
continue reading
1
Discussing Rheumatology: February 2024
10:17
10:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:17
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that show the long-term safety and efficacy of JAK inhibitors, both of which have a study period of 6.5 years. In our first paper, Roberto …
…
continue reading
1
PsA Podcast: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs
32:10
32:10
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
32:10
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the clinical response to guselkumab and the research surrounding sequential lines of b/tsDMARDs.Oleh The IMID Forum
…
continue reading
1
Ep 28. Writing a compelling case report
23:02
23:02
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
23:02
In this episode on how to write a compelling case report, Pippa Watson talks to Ai Lyn Tan, an Associate Professor and Honorary Consultant Rheumatologist at Chapel Allerton Hospital Leeds and Editor in Chief of the BSR Rheumatology Advances in Practice journal, and Caroline Groves, our Journal Development Manager at BSR. This podcast covers everyth…
…
continue reading
1
Author Interview: Dr Mahta Mortezavi, 2024
20:18
20:18
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
20:18
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Mahta Mortezavi, a Clinical Director for Drug Discovery and Early Development as part of the Anti-infectives Research Unit at Pfizer, as they discuss her recent paper ‘Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumour necros…
…
continue reading
1
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
16:04
16:04
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
16:04
Informative podcast this week with Dr. Alexander Oldroyd, the first author of the recently published "International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening." The article itself appeared in Nature Reviews Rheumatology and provides what I think is a very useful framework for approaching this issue. Article: https://…
…
continue reading
1
Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs
43:10
43:10
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
43:10
Join Professor Peter Nash from the Griffith University in Brisbane, as well as Professors Andrew Cope, Professor of Rheumatology and Head of the Centre for Rheumatic Diseases at Kings College London, Professor Paul Emery, Clinical Professor and Director of the Leeds Biomedical Research Centre, and Professor John Isaacs, Professor of clinical immuno…
…
continue reading
1
Author Interview: Dr Kehinde Sunmboye, 2024
18:05
18:05
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
18:05
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Kehinde Sunmboye, a consultant rheumatologist at the University Hospitals of Leicester NHS Trust, in this episode of the Author Interview series. Dr Sunmboye discusses his recent paper 'Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population' wit…
…
continue reading
1
E107: Fragility of SLE Randomized Controlled Trials
13:17
13:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
13:17
Quick methodology episode this week discussing the concept of "fragility" in randomized controlled trials of lupus. Really enjoyed discussing this paper and was grateful to have been a part of it. Get the text here: https://lupus.bmj.com/content/lupusscimed/11/1/e001068.full.pdfOleh Michael Putman
…
continue reading
In this episode, Sarah Gallagher talks to Dr Jo Ledingham and Dr Liz Price about all things NEIAA, from changes to data collection, findings from the 5-year report and how data can be used.Oleh British Society for Rheumatology
…
continue reading
Join Professor Iain McInnes for the first episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that aimed to advise on treatment of rheumatic diseases in a real-world setting. In our first paper, Emma Dures and her colleagues compiled t…
…
continue reading
1
AxSpA Podcast: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice
25:05
25:05
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
25:05
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the long-term impact of secukinumab treatment on bone-related outcomes and BTMs in r-AxSpA patients over two years. Our faculty then move on to disc…
…
continue reading
1
E106: GCA/PMR with Bhaskar Dasgupta
28:28
28:28
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
28:28
Today I'm taking another twitter discussion into the podcast realm! Dr. Bhaskar Dasgupta has published hundreds of papers about polymyalgia rheumatica and giant cell arteritis, including a recent publication in Nature Reviews: Rheumatology that piqued my interest (https://www.nature.com/articles/s41584-023-00976-8). In this podcast we discuss scree…
…
continue reading
1
Author Interview: Professor Andrea Rubbert-Roth, 2023
25:17
25:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
25:17
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrea Rubbert-Roth, a doctor of rheumatology and internal medicine at the Kantonsspital St Gallen in Switzerland, as they discuss her recent paper 'Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, a…
…
continue reading
1
PsA Podcast: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies
30:33
30:33
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
30:33
Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, namely the effect of sex on the long-term persistence of targeted therapies, as well as the impact of secukinumab on synovitis and enthesitis.…
…
continue reading
1
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?
17:53
17:53
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
17:53
Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear the findings and what this means for future clinic…
…
continue reading
Interesting topic and interesting paper this year, including discussion of observational biases, positive and negative controls, and interpreting data as it comes. Paper: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2810259Oleh Michael Putman
…
continue reading
In this important Talking Rheumatology Spotlight pod we will be talking about health disparities in our Rheumatology services and how we can help tackle them at both an individual and organisational level. Prepare to be inspired. To access the free training click here (120 mins) and the published article here.…
…
continue reading
1
Ep 41. Addressing the leaky pipeline
17:56
17:56
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
17:56
What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading l…
…
continue reading
1
Recent Updates on Management of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger
24:01
24:01
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
24:01
In this podcast, clinical experts discuss key findings presented during the past year on current and emerging therapies for managing uncontrolled gout.
…
continue reading
1
Evidence-Based Tools to Detect and Assess Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger
18:04
18:04
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
18:04
In this podcast, clinical experts discuss key findings presented during the past year on evidence-based tools for detection and assessment of uncontrolled gout.
…
continue reading
1
Burden and Complications of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger
21:11
21:11
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
21:11
In this podcast, clinical experts discuss key findings presented during the past year on disease burden and comorbidities associated with uncontrolled gout.
…
continue reading
1
AxSpA Podcast: Bimekizumab in AxSpA & Secukinumab Patient Clustering
26:26
26:26
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
26:26
Join us for the latest axSpA podcast brought to you by the CSF! This month Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Leiden University Medical Centre and Zuyderland Medical Centre, is joined once again by experts with a wealth of clinical knowledge. Joining her is Hideto Kameda, Professor of Internal Medicine at Toho Unive…
…
continue reading
1
Discussing Rheumatology: December 2023
10:37
10:37
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:37
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that compare the efficacy and safety of JAK inhibitors as RA therapies. In our first paper, Shinya Hayashi and his colleagues carried out a retrospective study to compare the efficacy o…
…
continue reading
1
PsA Podcast: Impact of Biological Sex on Advanced Therapies & Upadacitinib-related Malignancies
27:19
27:19
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
27:19
Join Philip Mease, Professor at the University of Washington School of Medicine and Director of Rheumatology Research at the Swedish Medical Centre in Seattle, USA, and Laura Coates, an Associate Professor, NIHR clinician scientist and senior clinical research fellow at the Oxford Psoriatic Arthritis Centre, as they discuss two important topics fro…
…
continue reading
1
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy
4:41
4:41
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
4:41
We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly pr…
…
continue reading
1
E104: Sarilumab for PMR - The SAPHYR Study
18:35
18:35
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
18:35
Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR. Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303…
…
continue reading
In this episode, Will Gregory talks to Dr Gordon Hendry about all things feet. Essential listening for all of the MDT, this podcast covers everything from the importance of examining feet to the use of ultrasound and the RADAI-F5.Oleh British Society for Rheumatology
…
continue reading
1
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
33:10
33:10
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
33:10
Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world of axSpA. In the first paper discussed, the authors evaluated the efficacy and safety of tofacitinib in bDMARD-naïve and TNF-IR AS patients. The second paper presents the results of two parallel clinic…
…
continue reading
1
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
21:09
21:09
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
21:09
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, Philip Mease, Professor at the University of Washington School of Medicine, and Director of Rheumatology Research at the Swedish Medical Centre in Seattle, USA, as well as Laura Coates, an Assoc…
…
continue reading
1
Ep 39. UK JIA Biologics Register: stopping biologics for remission
10:06
10:06
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:06
What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a …
…
continue reading
1
Discussing Rheumatology: November 2023
10:11
10:11
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
10:11
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that look at the incidence of disease. The first paper, the GBD 2021 Other Musculoskeletal Disorders Collaborators systematically analysed the global burden of musculoskeletal disorders…
…
continue reading
Join Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Wednesday 15 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!Oleh The IMID Forum
…
continue reading
Join Grace Wright as she goes through our top abstracts, posters, and presentations from Day 3 of ACR 2023 today (Tuesday 14 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!Oleh The IMID Forum
…
continue reading
Join Laura Coates as she goes through our top abstracts, posters, and presentations from Day 2 of ACR 2023 today (Monday 13 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!Oleh The IMID Forum
…
continue reading
Join Iain McInnes as he goes through our top abstracts, posters, and presentations from Day 1 of ACR 2023 today (Sunday 12 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!Oleh The IMID Forum
…
continue reading
Join Dr Sofia Ramiro as she previews our highlights this ACR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.Oleh The IMID Forum
…
continue reading
1
Ep 13. CAREERS - Paediatric rheumatology training
22:53
22:53
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
22:53
In this careers pod Dr Diarmuid McLaughlin talks to Dr Sharmila Jandial about training pathways for paediatric rheumatology including tips on finding out more about a career in Rheumatology, training pathways, subspecialty training and where it all can lead. Recommended for anyone thinking of getting involved.…
…
continue reading
1
Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA
21:21
21:21
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
21:21
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia and Laura Coates, an Associate Professor, NIHR clinician scientist and senior clinical research fellow at the Oxford Psoriatic Arthritis Centre, discussing two intriguing aspects of the contempor…
…
continue reading
1
Ep 12. CAREERS - Reasons for choosing rheumatology and different career paths
28:28
28:28
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
28:28
In this pod aimed at medical students medical student Edward Mbasoor talks to Associate Professor Ai Lyn Tan about a career in Rheumatology covering all things from; what Rheumatology is, reasons for choosing Rheumatology, career paths and how to find out more about the specialty. A must listen for anyone considering Rheumatology as a career.…
…
continue reading
1
axSpA Podcast: Safety and Efficacy of Upadacitinib
26:31
26:31
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
26:31
Professor Hideto Kameda, Professor of Internal Medicine at Toho University in Japan, is joined by Professor Xenofon Baraliakos, Professor of Internal Medicine and Rheumatology at the Ruhr-University in Bochum, and a senior consultant and scientific coordinator of the rheumatology centre Rheumazentrum Ruhrgebiet in Herne, Germany, Dr Sofia Ramiro, c…
…
continue reading
1
CSF Author Interview: Dr. David Martin, 2023
39:27
39:27
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
39:27
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr. David Martin, executive medical director at Pfizer in Massachusetts, USA as they discuss his recent paper 'Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors'Detailed summary …
…
continue reading
1
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study
7:19
7:19
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
7:19
Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDM…
…
continue reading
1
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
22:25
22:25
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
22:25
This week I took a twitter disagreement from the impersonal world of twitter to the podcast world of a back and forth conversation. Really enjoyed talking to Dr. Len Calabrese about monoclonal antibodies, FDA regulatory pathways, and life in general.Oleh Michael Putman
…
continue reading
1
Discussing Rheumatology: October 2023
11:17
11:17
Putar nanti
Putar nanti
Daftar
Suka
Menyukai
11:17
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that look at the epidemiology of autoimmune diseases. The first paper, the GBD 2021 Rheumatoid Arthritis Collaborators systematically reviewed the global RA burden, and used these data…
…
continue reading